Held in association with Med-Tech innovation, over 250 people from across the Healthcare and Life Sciences sector came together at the Ricoh Arena in Coventry on 25th April to celebrate success at the Medilink UK National Awards.
The awards recognised a multitude of outstanding business achievements, international successes and innovative breakthroughs made across the Life Sciences and Healthcare Technology sectors in the past year, with seven companies from across the UK being crowned as winners in their respective categories.
Having previously won the regional MediWales award in late 2017, it was once again CellPath who were toasting success at the national Medilink award ceremony, taking home the prestigious Export Achievement Award having demonstrated significant international growth alongside a solid expansion plan for the future.
Commenting on the award, Peter Webber, CellPath Chairman said:
“Once again, we are delighted that our hard work has been recognised through the winning of this award. CellPath has invested significantly in their international offering over the last few years and this is now beginning to pay off. The foundations for growth have been laid, and with further projects in the pipeline, it’s a very exciting time for the company”.
About MediLink UK
Medilink UK is a national health technology business support organisation, with a strong track record in increasing the viability of manufacturers, service providers, designers, OEMs and suppliers of medical technology.
Confronting the day-to-day issues that face businesses, Medilink UK helps companies from concept through to commercialisation and nurtures collaborations between academics, clinicians and industry. With a team of experts, Medilink UK can provide bespoke market research for companies diversifying into the sector or investing in research and development. On an international platform, Medilink UK supports global companies investing in the UK market as well as promoting the export of products and services to the US, Middle East and Asia.